New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis

被引:71
作者
Garcia de Viedma, D
Infantes, MDD
Lasala, F
Chaves, F
Alcalá, L
Bouza, E
机构
[1] Hosp Gen Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, Madrid 28007, Spain
[2] Hosp Doce Octubre, Microbiol Serv, Madrid, Spain
关键词
D O I
10.1128/JCM.40.3.988-995.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The emergence of resistance to antituberculosis drugs is a relevant matter worldwide, but the retrieval of antibiograms for Mycobacterium tuberculosis is severely delayed when phenotypic methods are used. Genotypic methods allow earlier detection of resistance, although conventional approaches are cumbersome or lack sensitivity or specificity. We aimed to design a new real-time PCR method to detect rifampin (RIF)- and isoniazid (INH)-resistant M. tuberculosis strains in a single reaction tube. First, we characterized the resistant isolates in our area of Spain by DNA sequencing. Some mutation was found within the rpoB core region in all the RIF-resistant (RIFr) strains. Forty-six percent of the INH-resistant (INHr) strains showed a mutation in katG codon 315, and most of these were associated with high MICs. Eighteen of the RIFr, INHr, and multidrug, resistant strains sequenced were tested by our real-time PCR assay; and full concordance of the results of the PCR with the sequencing data was obtained. In addition, a blind test was performed with a panel of 15 different susceptible and resistant strains from throughout Spain, and our results were also in 100% agreement with the sequencing data. Ours is the first assay based on rapid-cycle PCR able to simultaneously detect in a single reaction tube a large variety of mutations associated with RIF resistance (12 different mutations affecting 8 independent codons, including the most prevalent mutations at positions 526 and 531) and the most frequent INH resistance mutations. Our design could be a model for new, rapid genotypic methods able to simultaneously detect a wide variety of antibiotic resistance mutations.
引用
收藏
页码:988 / 995
页数:8
相关论文
共 28 条
  • [21] Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis
    Scarpellini, P
    Braglia, S
    Carrera, P
    Cedri, M
    Cichero, P
    Colombo, A
    Crucianelli, R
    Gori, A
    Ferrari, M
    Lazzarin, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2550 - 2554
  • [22] DETECTION OF RIFAMPICIN-RESISTANCE MUTATIONS IN MYCOBACTERIUM-TUBERCULOSIS
    TELENTI, A
    IMBODEN, P
    MARCHESI, F
    LOWRIE, D
    COLE, S
    COLSTON, MJ
    MATTER, L
    SCHOPFER, K
    BODMER, T
    [J]. LANCET, 1993, 341 (8846) : 647 - 650
  • [23] Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level
    Telenti, A
    Honore, N
    Bernasconi, C
    March, J
    Ortega, A
    Heym, B
    Takiff, HE
    Cole, ST
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) : 719 - 723
  • [24] THE RESURGENCE OF TUBERCULOSIS - IS YOUR LABORATORY READY
    TENOVER, FC
    CRAWFORD, JT
    HUEBNER, RE
    GEITER, LJ
    HORSBURGH, CR
    GOOD, RC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (04) : 767 - 770
  • [25] Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis
    Torres, MJ
    Criado, A
    Palomares, JC
    Aznar, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3194 - 3199
  • [26] Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands
    van Soolingen, D
    de Haas, PEW
    van Doorn, HR
    Kuijper, E
    Rinder, H
    Borgdorff, MW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1788 - 1790
  • [27] Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis
    Williams, DL
    Spring, L
    Collins, L
    Miller, LP
    Heifets, LB
    Gangadharam, PRJ
    Gillis, TP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1853 - 1857
  • [28] 1990, JAMA, V264, P173